SLC5A2 and chronic kidney disease: The use of SGLT2 inhibitors is only suggested (instead of recommended) in CKD patients with an eGFR at least 20/ml/min/1.73 m2 without albuminuria (UACR < 200 mg/g or <20 mg/mmol) [5▪▪].